Keyword | CPC | PCC | Volume | Score |
---|---|---|---|---|
ianalumab for waiha clinical study result | 0.88 | 0.1 | 4871 | 56 |
ianalumab mechanism of action | 1.7 | 0.1 | 7664 | 64 |
mechanism of action of nivolumab | 1.43 | 0.4 | 4465 | 63 |
ipilimumab and nivolumab mechanism of action | 1.11 | 0.1 | 2674 | 4 |
ibalizumab mechanism of action | 0.07 | 0.6 | 9418 | 78 |
mechanism of action of adalimumab | 1.71 | 0.6 | 8563 | 7 |
nip adalimumab mechanism of action | 1.74 | 1 | 7873 | 91 |
erenumab mechanism of action | 0.32 | 1 | 4651 | 24 |
alirocumab mechanism of action | 0.35 | 0.5 | 1611 | 81 |
mechanism of action of omalizumab | 0.4 | 0.3 | 6166 | 72 |
lanadelumab mechanism of action | 0.34 | 0.2 | 2266 | 26 |
burosumab mechanism of action | 0.62 | 0.8 | 645 | 32 |
nivolumab mode of action | 0.33 | 0.7 | 1385 | 77 |
panitumumab mechanism of action | 1.48 | 0.7 | 4328 | 96 |
enfortumab mechanism of action | 0.34 | 0.3 | 7345 | 78 |
nivolumab for renal cell mechanism of action | 1.05 | 1 | 172 | 64 |
parameter adalimumab mechanism of action | 0.86 | 0.8 | 7963 | 67 |
evinacumab mechanism of action | 1.89 | 1 | 6611 | 6 |